Host PrP Glycosylation: A Major Factor Determining the Outcome of Prion Infection

• Nadia L Tuzi ,

  Contributed equally to this work with: Nadia L Tuzi, Enrico Cancellotti

  Affiliation Neuropathogenesis Unit, Roslin Institute, Edinburgh, United Kingdom

  ⨯
• Enrico Cancellotti ,

  Contributed equally to this work with: Nadia L Tuzi, Enrico Cancellotti

  Affiliation Neuropathogenesis Unit, Roslin Institute, Edinburgh, United Kingdom

  ⨯
• Herbert Baybutt,

  Affiliation Neuropathogenesis Unit, Roslin Institute, Edinburgh, United Kingdom

  ⨯
• Lorraine Blackford,

  Affiliation Neuropathogenesis Unit, Roslin Institute, Edinburgh, United Kingdom

  ⨯
• Barry Bradford,

  Affiliation Neuropathogenesis Unit, Roslin Institute, Edinburgh, United Kingdom

  ⨯
• Chris Plinston,

  Affiliation Neuropathogenesis Unit, Roslin Institute, Edinburgh, United Kingdom

  ⨯
• Anne Coghill,

  Affiliation Neuropathogenesis Unit, Roslin Institute, Edinburgh, United Kingdom

  ⨯
• Patricia Hart,

  Affiliation Neuropathogenesis Unit, Roslin Institute, Edinburgh, United Kingdom

  ⨯
• Pedro Piccardo,

  Affiliation Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, Maryland, United States of America

  ⨯
• Rona M Barron,

  Affiliation Neuropathogenesis Unit, Roslin Institute, Edinburgh, United Kingdom

  ⨯
• Jean C Manson

  *To whom correspondence should be addressed. E-mail: jean.manson@roslin.ed.ac.uk

  Affiliation Neuropathogenesis Unit, Roslin Institute, Edinburgh, United Kingdom

  ⨯